226 related articles for article (PubMed ID: 27875105)
1. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.
Maxwell AWP; Baird GL; Iannuccilli JD; Mayo-Smith WW; Dupuy DE
Radiology; 2017 May; 283(2):590-597. PubMed ID: 27875105
[TBL] [Abstract][Full Text] [Related]
2. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
4. External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index.
Antonelli A; Veccia A; Sandri M; Furlan MC; Recenti S; Sodano M; Palumbo C; Cozzoli A; Simeone C
Clin Genitourin Cancer; 2018 Jun; 16(3):e595-e604. PubMed ID: 29174503
[TBL] [Abstract][Full Text] [Related]
5. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
6. Renal tumour anatomical characteristics and functional outcome after partial nephrectomy.
Nisen H; Heimonen P; Kenttä L; Visapää H; Nisen J; Taari K
Scand J Urol; 2015 Jun; 49(3):193-9. PubMed ID: 25385687
[TBL] [Abstract][Full Text] [Related]
7. R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected Cohort.
Borgmann H; Reiss AK; Kurosch M; Filmann N; Frees S; Mager R; Tsaur I; Haferkamp A
J Urol; 2016 Sep; 196(3):664-71. PubMed ID: 27091569
[TBL] [Abstract][Full Text] [Related]
8. Interdisciplinary Comparison of PADUA and R.E.N.A.L. Scoring Systems for Prediction of Conversion to Nephrectomy in Patients with Renal Mass Scheduled for Nephron Sparing Surgery.
Dahlkamp L; Haeuser L; Winnekendonk G; von Bodman C; Frey UH; Epplen R; Palisaar RJ; Bach P; Noldus J; Brock M; Roghmann F
J Urol; 2019 Nov; 202(5):890-898. PubMed ID: 31145034
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
[TBL] [Abstract][Full Text] [Related]
10. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
11. Can RENAL and PADUA nephrometry indices predict complications of laparoscopic cryoablation for clinical stage T1 renal tumors?
Lagerveld BW; Brenninkmeijer M; van der Zee JA; van Haarst EP
J Endourol; 2014 Apr; 28(4):464-71. PubMed ID: 24228738
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
13. Simplified PADUA Renal (SPARE) Nephrometry Scoring System: External Validation, Interobserver Variability, and Comparison with RENAL and PADUA in a Single-center Robotic Partial Nephrectomy Series.
Weprin S; Falagario U; Veccia A; Nandanan N; Emerson D; Ovanez C; Albuquerque EV; Zukovski EB; Clayton R; Hampton L; Autorino R
Eur Urol Focus; 2021 May; 7(3):591-597. PubMed ID: 32591285
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Assessment of Renal Sinus Invasion by Renal Cell Carcinoma according to Tumor Complexity and Imaging Features in Patients Undergoing Radical Nephrectomy.
Kim JH; Park KJ; Kim MH; Kim JK
Korean J Radiol; 2021 Aug; 22(8):1323-1331. PubMed ID: 34047502
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
[TBL] [Abstract][Full Text] [Related]
17. PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database.
Schiavina R; Novara G; Borghesi M; Ficarra V; Ahlawat R; Moon DA; Porpiglia F; Challacombe BJ; Dasgupta P; Brunocilla E; La Manna G; Volpe A; Verma H; Martorana G; Mottrie A
BJU Int; 2017 Mar; 119(3):456-463. PubMed ID: 27528265
[TBL] [Abstract][Full Text] [Related]
18. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
[TBL] [Abstract][Full Text] [Related]
20. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
